ResMed Inc (RMD)
236.17
-0.23
(-0.10%)
USD |
NYSE |
Jan 08, 16:00
236.24
+0.07
(+0.03%)
After-Hours: 20:00
ResMed SG&A Expense (Quarterly): 238.98M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 1.562B |
| Haemonetics Corp | 106.95M |
| Globus Medical Inc | 240.74M |
| Abbott Laboratories | 2.895B |
| Zimmer Biomet Holdings Inc | 709.70M |